INS and autoimmune disease: T1D is an autoimmune disease resulting in the inability to produce insulin and metabolize glucose, necessitating self‐management through counting carbohydrates and proportionate administration of insulin through multiple daily injections or constant subcutaneous insulin infusion (“insulin pump”).